Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review

GlobalData
64 Pages - GLDATA60690
$125.00

Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-center dialysis solutions, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The products find application in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers and clinics. The company distributes its products through its own direct sales force; independent distributors, drug wholesalers acting as sales agents and specialty pharmacies or other alternate site providers. It has wide spread operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

Baxter International Inc Key Recent Developments

Feb 08,2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
Feb 01,2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
Jan 19,2017: Baxter’s Renal Therapy Services Significantly Reduced Peritonitis Infections among Home Dialysis Patients
Nov 22,2016: Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy
Nov 21,2016: New Data Presented at ASN Kidney Week Spotlight Baxter's SHARESOURCE Telehealth Platform and AMIA APD System in Supporting More Efficient Home Dialysis Care

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

'

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Baxter International Inc - Key Facts 6
Baxter International Inc - Key Employees 7
Baxter International Inc - Key Employee Biographies 8
Baxter International Inc - Major Products and Services 9
Baxter International Inc - Medical Equipment Pipeline Products Data 12
Baxter International Inc Pipeline Products by Equipment Type 12
Baxter International Inc Pipeline Products by Development Stage 13
Baxter International Inc - History 16
Baxter International Inc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Affiliate 30
Joint Venture 30
Section 2 – Company Analysis 31
Baxter International Inc - Business Description 31
Business Description - Hospital Products 31
Hospital Products - Overview 31
Hospital Products - Financials 31
Business Description - Renal 31
Renal - Overview 31
Renal - Financials 32
Baxter International Inc - Corporate Strategy 33
Baxter International Inc - SWOT Analysis 34
SWOT Analysis - Overview 34
Baxter International Inc - Strengths 34
Baxter International Inc - Weaknesses 35
Baxter International Inc - Opportunities 36
Baxter International Inc - Threats 37
Baxter International Inc - Key Competitors 38
Section 3 – Company Financial Ratios 39
Financial Ratios - Capital Market Ratios 39
Financial Ratios - Annual Ratios 40
Performance Chart 42
Financial Performance 42
Financial Ratios - Interim Ratios 43
Financial Ratios - Ratio Charts 44
Section 4 – Company’s Lifesciences Financial Deals and Alliances 45
Baxter International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 45
Baxter International Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 46
Baxter International Inc, Recent Deals Summary 47
Section 5 – Company’s Recent Developments 48
Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 48
Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 49
Nov 22, 2016: Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy 51
Nov 21, 2016: New Data Presented at ASN Kidney Week Spotlight Baxter's SHARESOURCE Telehealth Platform and AMIA APD System in Supporting More Efficient Home Dialysis Care 52
Nov 17, 2016: Baxter to Present 24 Abstracts at ASN Kidney Week 2016 Focused on Elevating the Standard of Care For Dialysis Patients Globally 53
Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 54
Sep 08, 2016: Baxter Recognized for 17th Consecutive Year by Dow Jones Sustainability Index (DJSI) as Responsible and Sustainable Business 55
Jul 27, 2016: Baxter Presents New Evidence Demonstrating REVACLEAR Dialyzer Associated with Lower Drug Use During Hemodialysis 56
Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 57
May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 59
Section 6 – Appendix 60
Methodology 60
Ratio Definitions 60
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Baxter International Inc, Key Facts 6
Baxter International Inc, Key Employees 7
Baxter International Inc, Key Employee Biographies 8
Baxter International Inc, Major Products and Services 9
Baxter International Inc Pipeline Products by Equipment Type 12
Baxter International Inc Number of Pipeline Products by Development Stage 13
Baxter International Inc Pipeline Products Summary by Development Stage 14
Baxter International Inc, History 16
Baxter International Inc, Other Locations 24
Baxter International Inc, Subsidiaries 24
Baxter International Inc, Affiliate 30
Baxter International Inc, Joint Venture 30
Baxter International Inc, Key Competitors 38
Baxter International Inc, Ratios based on current share price 39
Baxter International Inc 40
Baxter International Inc (Cont...1) 41
Baxter International Inc, Interim Ratios 43
Baxter International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 45
Baxter International Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 46
Baxter International Inc, Recent Deals Summary 47
Currency Codes 60
Capital Market Ratios 60
Equity Ratios 61
Profitability Ratios 61
Cost Ratios 62
Liquidity Ratios 62
Leverage Ratios 63
Efficiency Ratios 63

List of Figures
Baxter International Inc Pipeline Products by Equipment Type 12
Baxter International Inc Pipeline Products by Development Stage 13
Baxter International Inc, Performance Chart (2012 - 2016) 42
Baxter International Inc, Ratio Charts 44
Baxter International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 45
Baxter International Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 46

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838